Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Primary Cardiomyocytes

By R&D Editors | February 24, 2011

ATCC (American Type Culture Collection), the world’s largest and most diverse bioresource center, offers primary cardiomyocytes isolated from adult human tissue. Unlike cardiomyocytes derived from human ES or iPS cells, these heart muscle cells propagate in culture with high viability and plating efficiency. ATCC Cardiomyocytes are ideal for research related to heart disease, tissue regeneration, drug screening, preclinical cardiotoxicity and cell signaling studies involving voltage potential measurement of ion channel and ion pump transporters.

ATCC Normal Primary Cardiomyocytes are one part of ATCC Primary Cell Solutions, a system of matched components that include cryopreserved cells, optimized media, growth factors and reagents for cell culture. Complete Cardiomyocyte Growth Medium consists of Vascular Cell Basal Media, a sterile, phenol red-free liquid tissue culture medium, supplemented with the Cardiomyocyte Cell Growth Kit. The kit is comprised of several purified recombinant human (rh) growth factors, including rh FGF-basic, rh insulin and rh EGF/rh TGF-?1, in addition to FBS and fetuin. ATCC warrants the viability and growth performance of Normal Primary Cardiomyocytes when grown in Complete Cardiomyocyte Growth Medium. Scientists no longer require additional components such as feeder layers, extracellular matrix proteins or other substrates.

Normal Primary Cardiomyocytes from ATCC are cryopreserved in the second passage, assuring the highest purity. The cells have undergone sterility testing for bacteria, yeast, fungi and mycoplasma, and shown to be negative for HIV-1, HIV-2, HBV and  HCV. Each lot is supplied with a certificate of analysis upon request. Scientists can expect cell cultures with functional expression of relevant biomarkers, normal morphology and superior growth and proliferation. ATCC Primary Cell Solutions systems enable researchers to grow high quality cultures reliably and consistently — with expert support if needed.

American Type Culture Collection

Related Articles Read More >

New nanopore sensor paves the way for fast, accurate, low-cost DNA sequencing
E. coli makes Tylenol from plastic waste
2025 R&D layoffs tracker hits 132,075 as Amazon CEO signals AI will cut more jobs
Probiotics power a bioresorbable battery that can run from 4 to 100+ minutes
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE